{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:01:39Z","timestamp":1774681299167,"version":"3.50.1"},"reference-count":59,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1645,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1600-0404.2010.01394.x","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T01:48:12Z","timestamp":1277171292000},"page":"257-265","source":"Crossref","is-referenced-by-count":54,"title":["Intravenous sodium valproate aborts migraine headaches rapidly"],"prefix":"10.1155","volume":"123","author":[{"given":"R.","family":"Shahien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bowirrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB1|cit1","first-page":"S6","article-title":"Migrane in the United States: a review of epidemiology and health care use","volume":"43","author":"Lipton","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for prevalence therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.267.1.64","article-title":"Prevalence of migraine headache in the United states: relation to age, income, race, and other sociodemographic factors","volume":"267","author":"Stewart","year":"1992","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1526-4610.2008.01117_1.x","article-title":"A pivotal moment in 50\u2003years of headache history: the first American migraine study","volume":"48","author":"Tepper","year":"2008","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1526-4610.1986.hed2604168.x","article-title":"A controlled study of dihydroergotamine in the treatment of acute migraine headache","volume":"26","author":"Callaham","year":"1986","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.265.21.2831","article-title":"Treatment of acute migraine with subcutaneous sumatriptan","volume":"265","author":"Cady","year":"1991","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archneur.1992.00530360073020","article-title":"Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine","volume":"49","author":"Mathew","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1468-2982.1997.1705591.x","article-title":"Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study","volume":"17","author":"Carpay","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1526-4610.1991.hed3108523.x","article-title":"Ketorolac vesus DHE and metoclopramide in the treatment of migraine headaches","volume":"31","author":"Klapper","year":"1991","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1212\/WNL.45.6.1211","article-title":"Cardiac arrest following use of sumatriptan","volume":"45","author":"Kelly","year":"1995","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00002018-199513030-00001","article-title":"Analgesic rebound headache. How great is the problem and what can be done","volume":"13","author":"Silberstein","year":"1995","journal-title":"Drug Saf"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"Freitag","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-2982.1997.1702093.x","article-title":"Possible mechanisms of valproate in migraine prophylaxis","volume":"17","author":"Cutrer","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1468-2982.1994.1404305-2.x","article-title":"Sodium valproate for acute migraine attacks","volume":"14","author":"Hering","year":"1994","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1526-4610.2000.00125.x","article-title":"Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report","volume":"40","author":"Mathew","year":"2000","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1526-4610.2001.01191.x","article-title":"Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache","volume":"41","author":"Edwards","year":"2001","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mem.2003.195","article-title":"Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial","volume":"41","author":"Tanen","year":"2003","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1526-4610.2005.05009.x","article-title":"Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks","volume":"45","author":"Leniger","year":"2005","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1526-4610.2000.00133.x","article-title":"Use of intravenous valproate sodium in status migraine","volume":"40","author":"Norton","year":"2000","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1526-4610.2002.02127.x","article-title":"Intravenous valproate sodium in the treatment of daily headache","volume":"42","author":"Schwartz","year":"2002","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1526-4610.2004.04010.x","article-title":"Treatment of primary headache disorders with intravenous valproate: initial outpatient experience","volume":"44","author":"Stillman","year":"2004","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1526-4610.1996.3610579.x","article-title":"Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain","volume":"36","author":"Cutrer","year":"1996","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.bjp.0704325","article-title":"GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex","volume":"134","author":"Storer","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-2982.2007.01513.x","article-title":"Intravenous valproate aborts glyceryl trinitrateinduced migraine attacks: a clinical and quantitative EEG study","volume":"28","author":"Thomaides","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0404.1988.tb03667.x","article-title":"Valpoate: a new drug in migraine prophylaxis","volume":"78","author":"Sorensen","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/mf.1998.20.4.485692","article-title":"Prophylactic sodium valproate in patients with drug-resistant migraine","volume":"20","author":"Ghose","year":"1998","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2165\/00003495-199856050-00006","article-title":"A practical guide to the management and prevention of migraine","volume":"56","author":"Dlener","year":"1998","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(85)90718-8","article-title":"Inhibitory influence of nuclei as the neuroanatomical site of GABAergic inhibition of cerebral serotonergic neurons","volume":"331","author":"Nishikawa","year":"1985","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB29|cit29","first-page":"96","article-title":"Valproate reduces c-fos expression in trigeminal nucleus caudalis (TNC) after noxious meningeal stimulation [abstract]","volume":"14","author":"Cutrer","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1526-4610.1996.3610579.x","article-title":"The actions of valproate and neurosteroids in a model of trigeminal pain","volume":"36","author":"Cutrer","year":"1996","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/NMM:6:2-3:105","article-title":"Functional effects of Na+,K+-ATPase gene mutations linked to familial hemiplegic migraine","volume":"6","author":"Capendeguy","year":"2004","journal-title":"Neuromolecular Med"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jama.301.24.2608","article-title":"Migraine headache","volume":"301","author":"Hildreth","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/cercor\/12.5.515","article-title":"Similar perisynaptic glial localization for the Na+,K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex","volume":"12","author":"Cholet","year":"2002","journal-title":"Cereb Cortex"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1523\/JNEUROSCI.0721-07.2007","article-title":"High-resolution in vivo imaging of the neurovascular unit during spreading depression","volume":"27","author":"Chuquet","year":"2007","journal-title":"J Neurosci"},{"issue":"Suppl","key":"10.1111\/j.1600-0404.2010.01394.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1139\/y92-265","article-title":"Potassium and sodium transport and pH regulation","volume":"70","author":"Clausen","year":"1992","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1526-4610.1980.hed2006294.x","article-title":"Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers","volume":"20","author":"Anselmi","year":"2005","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1526-4610.1989.hed2908494.x","article-title":"Low CSF Met-enkephalin levels in cluster headache are elevated by acupuncture","volume":"29","author":"Hardebo","year":"2005","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1526-4610.1985.hed2505259.x","article-title":"Plasma methionine enkephalin levels - a biological marker for migraine?","volume":"25","author":"Mosnaim","year":"2005","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1468-1331.2002.00334.x","article-title":"Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS","volume":"9","author":"Mulleners","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1111\/j.1476-5381.1995.tb15124.x","article-title":"Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin","volume":"116","author":"Cutrer","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB41|cit41","volume-title":"Headache in clinical practice","author":"Silberstein","year":"1998"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/0006-2952(85)90645-8","article-title":"In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities","volume":"34","author":"Loscher","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1476-5381.1995.tb16388.x","article-title":"Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma extravasations to substance P and trigeminal stimulation","volume":"116","author":"Lee","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB44|cit44","first-page":"1747","article-title":"Valproate induced changes in GABA metabolism at the subcellular level","volume":"34","author":"Loscher","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.1995.00540270077022","article-title":"Migraine prophylaxis with divalproex","volume":"52","author":"Mathew","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1034\/j.1600-0404.2000.102006354.x","article-title":"Valproic acid in prophylaxis of refractory migraine","volume":"102","author":"Erdemoglu","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.59.7.1084","article-title":"Mechanisms of action of the 5-HT1B\/1D receptor agonists","volume":"59","author":"Tepper","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-0348-8845-5_6","article-title":"Serotonin in migraine: theories, animal models and emerging therapies","volume":"51","author":"Johnson","year":"1998","journal-title":"Prog Drug Res"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB49|cit49","first-page":"5","article-title":"Intravenous sodium injection for prolonged migraine headache","volume":"11","author":"Robbins","year":"2001","journal-title":"Am J Pain Manag"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valporate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1471-4159.1980.tb11250.x","article-title":"Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake and metabolism of GABA","volume":"34","author":"Loscher","year":"1980","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(91)90078-A","article-title":"Volproate suppresses N-methyl-D-aspartate evoked, transient depolarizations in the rat neocortex in vitro","volume":"544","author":"Zeise","year":"1991","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(88)90002-7","article-title":"Marked increase in anticonvulsant activity but decrease in wet-dog shake behavior during short-term treatment of amygdale-kindled rats with valproic acid","volume":"150","author":"Loscher","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-0327(95)00025-I","article-title":"GABA and mood disorders: a brief review and hypothesis","volume":"34","author":"Petty","year":"1995","journal-title":"J Affect Disord"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB56|cit56","first-page":"205","article-title":"Valporate affects glutamate but not GABA receptors","volume":"9","author":"Mubhoff","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-0179-4-21","article-title":"Treating bipolar disorder in patients with renal failure having haemodialysis: two case reports","volume":"4","author":"Maneesh Gupta","year":"2008","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB58|cit58","first-page":"433","article-title":"Intravenous valproate sodium in the treatment of intractable migraines in the headache clinic","volume":"21","author":"Krusz","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01394.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1526-4610.2000.040008672.x","article-title":"The efficacy of divalproex sodium in the prophylactic treatment of children with migraine","volume":"40","author":"Caruso","year":"2000","journal-title":"Headache"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2010.01394.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2010.01394.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:48:56Z","timestamp":1671540536000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2010.01394.x"}},"subtitle":["Intravenous sodium valproate aborts migraine headache"],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01394.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}